| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |